[go: up one dir, main page]

HK40026825B - Ezh2抑制剂的盐形式 - Google Patents

Ezh2抑制剂的盐形式 Download PDF

Info

Publication number
HK40026825B
HK40026825B HK42020016780.7A HK42020016780A HK40026825B HK 40026825 B HK40026825 B HK 40026825B HK 42020016780 A HK42020016780 A HK 42020016780A HK 40026825 B HK40026825 B HK 40026825B
Authority
HK
Hong Kong
Prior art keywords
degrees
compound
cancer
polymorph
cell
Prior art date
Application number
HK42020016780.7A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK40026825A (zh
Inventor
Kevin Wayne Kuntz
Kuan-Chun Huang
Hyeong Wook Choi
Kristen SANDERS
Steven Mathieu
Arani CHANDA
Frank Fang
Original Assignee
Epizyme, Inc.
Eisai R&D Management Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Epizyme, Inc., Eisai R&D Management Co., Ltd. filed Critical Epizyme, Inc.
Publication of HK40026825A publication Critical patent/HK40026825A/zh
Publication of HK40026825B publication Critical patent/HK40026825B/zh

Links

HK42020016780.7A 2012-04-13 2020-09-24 Ezh2抑制剂的盐形式 HK40026825B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261624215P 2012-04-13

Publications (2)

Publication Number Publication Date
HK40026825A HK40026825A (zh) 2021-01-15
HK40026825B true HK40026825B (zh) 2023-06-02

Family

ID=

Similar Documents

Publication Publication Date Title
US12251386B2 (en) Salt form of a human histone methyltransferase EZH2 inhibitor
HK40087682A (zh) 用於抑制ezh2的hbr盐形式
HK40026825B (zh) Ezh2抑制剂的盐形式
HK40026825A (zh) Ezh2抑制剂的盐形式